Patents by Inventor Henk Swart

Henk Swart has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Fulvestrant compositions and method of use
    Patent number: 11452729
    Abstract: Provided are inclusion complexes comprising fulvestrant and a cyclodextrin. The complexes may be useful for treating various conditions, such as cancer and systemic lupus erythematosus. Also provided are methods of producing the inclusion complexes, methods of using the inclusion complexes in therapy, and kits and unit dosages comprising the complexes.
    Type: Grant
    Filed: July 17, 2020
    Date of Patent: September 27, 2022
    Assignee: SHIMODA BIOTECH (PTY) LTD
    Inventor: Henk Swart
  • FULVESTRANT COMPOSITIONS AND METHOD OF USE
    Publication number: 20210315905
    Abstract: Provided are inclusion complexes comprising fulvestrant and a cyclodextrin. The complexes may be useful for treating various conditions, such as cancer and systemic lupus erythematosus. Also provided are methods of producing the inclusion complexes, methods of using the inclusion complexes in therapy, and kits and unit dosages comprising the complexes.
    Type: Application
    Filed: July 17, 2020
    Publication date: October 14, 2021
    Applicant: Shimoda Biotech (PTY) Ltd
    Inventor: Henk SWART
  • FULVESTRANT COMPOSITIONS AND METHOD OF USE
    Publication number: 20200345751
    Abstract: Provided are inclusion complexes comprising fulvestrant and a cyclodextrin. The complexes may be useful for treating various conditions, such as cancer and systemic lupus erythematosus. Also provided are methods of producing the inclusion complexes, methods of using the inclusion complexes in therapy, and kits and unit dosages comprising the complexes.
    Type: Application
    Filed: July 17, 2020
    Publication date: November 5, 2020
    Applicant: Shimoda Biotech (PTY) Ltd
    Inventor: Henk SWART
  • Fulvestrant compositions and method of use
    Patent number: 10758547
    Abstract: Provided are inclusion complexes comprising fulvestrant and a cyclodextrin. The complexes may be useful for treating various conditions, such as cancer and systemic lupus erythematosus. Also provided are methods of producing the inclusion complexes, methods of using the inclusion complexes in therapy, and kits and unit dosages comprising the complexes.
    Type: Grant
    Filed: June 6, 2017
    Date of Patent: September 1, 2020
    Assignee: Shimoda Biotech (PTY) Ltd
    Inventor: Henk Swart
  • FULVESTRANT COMPOSITIONS AND METHOD OF USE
    Publication number: 20180071309
    Abstract: Provided are inclusion complexes comprising fulvestrant and a cyclodextrin. The complexes may be useful for treating various conditions, such as cancer and systemic lupus erythematosus. Also provided are methods of producing the inclusion complexes, methods of using the inclusion complexes in therapy, and kits and unit dosages comprising the complexes.
    Type: Application
    Filed: June 6, 2017
    Publication date: March 15, 2018
    Inventor: Henk Swart
  • FULVESTRANT COMPOSITIONS AND METHOD OF USE
    Publication number: 20170266203
    Abstract: Provided are inclusion complexes comprising fulvestrant and a cyclodextrin. The complexes may be useful for treating various conditions, such as cancer and systemic lupus erythematosus. Also provided are methods of producing the inclusion complexes, methods of using the inclusion complexes in therapy, and kits and unit dosages comprising the complexes.
    Type: Application
    Filed: June 6, 2017
    Publication date: September 21, 2017
    Inventor: Henk Swart
  • Fulvestrant compositions and methods of use
    Patent number: 9724355
    Abstract: Provided are inclusion complexes comprising fulvestrant and a cyclodextrin. The complexes may be useful for treating various conditions, such as cancer and systemic lupus crythematosus. Also provided are methods of producing the inclusion complexes, methods of using the inclusion complexes in therapy, and kits and unit dosages comprising the complexes.
    Type: Grant
    Filed: September 16, 2011
    Date of Patent: August 8, 2017
    Assignee: SHIMODA BIOTECH (PTY) LTD
    Inventor: Henk Swart
  • FULVESTRANT COMPOSITIONS AND METHODS OF USE
    Publication number: 20130274236
    Abstract: Provided are inclusion complexes comprising fulvestrant and a cyclodextrin. The complexes may be useful for treating various conditions, such as cancer and systemic lupus crythematosus. Also provided are methods of producing the inclusion complexes, methods of using the inclusion complexes in therapy, and kits and unit dosages comprising the complexes.
    Type: Application
    Filed: September 16, 2011
    Publication date: October 17, 2013
    Applicant: SHIMODA BIOTECH (PTY) LTD
    Inventor: Henk Swart
  • INCLUSION COMPLEXES OF ALPHA-CYCLODEXTRIN AND SILDENAFIL SALT
    Publication number: 20100184722
    Abstract: Provided are inclusion complexes comprising a sildenafil salt (e.g., sildenafil citrate) and alpha-cyclodextrin. The complexes may be useful treating various conditions, such as male erectile dysfunction and pulmonary hypertension. In some instances the inclusion complexes increase the solubility of sildenafil. Also provided are methods of producing the inclusion complexes, as well as methods of treatment, kits and unit dosages.
    Type: Application
    Filed: December 18, 2009
    Publication date: July 22, 2010
    Applicant: Shimoda Biotech (Pty) Ltd
    Inventors: Henk Swart, Steyn Knoetze